Taiyen Biotech Co., Ltd. (TPE:1737)

Taiyen Biotech Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	3,278	3,308	3,238	3,409	3,614	4,096
Revenue Growth	1.05%	2.15%	-5.01%	-5.67%	-11.77%	30.84%
Gross Profit Gross Profit Growth	1,336	1,341	1,321	1,257	1,277	1,373
Operating Income Operating Income Growth	490.91	474.19	354.54	321.44	445.05	529.18
Net Income Net Income Growth	397.04	399.87	371.52	300.39	426.7	393.23
Earnings Per Share EPS Growth	1.97	1.99	1.85	1.50	2.13	1.96
EPS Growth	8.24%	7.57%	23.33%	-29.58%	8.67%	7.69%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Biotechnology Cleaning and Maintenance Department Biotechnology Cleaning and Maintenance Department Growth	452.15	470.07	470.57	474.59	515.91	432.37
Engineering and Labor Department Engineering and Labor Department Growth	104.84	88.59	94.47	319.25	570.36	1,254
Other Department Other Department Growth	110	104.68	84.31	80.73	66.15	61.88
Adjustments and Eliminations Adjustments and Eliminations Growth	-29.66	-25.46	-18.75	-102.24	-20.64	-23.32
Salt Products and Packaged Water Salt Products and Packaged Water Growth	2,641	2,670	2,608	2,636	2,482	2,370
Total Total Growth	3,278	3,308	3,238	3,409	3,614	4,096

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,803	1,746	1,938	1,840	1,882	2,080
Total Debt Total Debt Growth	118.94	125.52	205.2	220.17	135.44	391.98
Net Cash (Debt) Net Cash Growth	1,684	1,620	1,733	1,619	1,747	1,688
Net Cash Growth	3.14%	-6.49%	7.00%	-7.29%	3.46%	0.42%
Net Cash Per Share Net Cash Per Share Growth	8.39	8.07	8.64	8.08	8.71	8.42

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	640.13	432.05	660.12	454.54	580.69	600.08
Capital Expenditures CapEx Growth	-308.98	-300.16	-307.61	-341.65	-246.11	-388.79
Free Cash Flow Free Cash Flow Growth	331.15	131.89	352.51	112.89	334.58	211.29
Free Cash Flow Growth	35.56%	-62.59%	212.26%	-66.26%	58.35%	183.28%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	40.77%	40.54%	40.79%	36.89%	35.33%	33.53%
Operating Margin	14.98%	14.34%	10.95%	9.43%	12.32%	12.92%
Pretax Margin	15.13%	14.93%	13.37%	9.65%	14.68%	12.45%
Profit Margin	12.11%	12.09%	11.47%	8.81%	11.81%	9.60%
FCF Margin	10.10%	3.99%	10.89%	3.31%	9.26%	5.16%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	1.400	1.400	1.300	1.200	1.500	1.500
Dividend Per Share Growth	8.33%	7.69%	8.33%	-20.00%	0%	11.11%
Dividend Yield	4.35%	4.42%	4.17%	3.78%	5.21%	5.32%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	16.32	15.86	17.47	22.77	15.21	16.89
Forward PE	-	15.52	15.52	15.52	15.52	15.52
P/FCF Ratio	19.42	48.07	18.41	60.59	19.40	31.43
PS Ratio	1.96	1.92	2.00	2.01	1.80	1.62

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error